# Soluble Beta-glucan (SBG) as Treatment for Diabetic Foot Ulcers

> **NCT00632008** · PHASE3 · COMPLETED · sponsor: **Biotec Pharmacon ASA** · enrollment: 122 (actual)

## Conditions studied

- Chronic Diabetic Foot Ulcers

## Interventions

- **DRUG:** Soluble beta-glucan (SBG)
- **DRUG:** Placebo comparator

## Key facts

- **NCT ID:** NCT00632008
- **Lead sponsor:** Biotec Pharmacon ASA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2009-08
- **Final completion:** 2009-10
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2010-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00632008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00632008, "Soluble Beta-glucan (SBG) as Treatment for Diabetic Foot Ulcers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00632008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*